Collaborative research effort underscores the urgent need for effective second-line therapies in this rare, aggressive cancer
Combining RFA with stenting improves survival rates, reduces post-ERCP complications
A call for awareness about the importance of genomic testing
Atypical cells discovered after primary sclerosing cholangitis diagnosis
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement